Anavex Life Sciences Corp (AVXL)

[nidan7500]

“This is a remarkable first strong signal for patients with Rett syndrome especially given that the strong effects were seen in adult patients, and we look forward to discussing these results with the FDA and the European regulatory agency as we continue our Rett Syndrome Program including pediatric patients,” said Walter E Kaufmann, MD, Principal Investigator of the study and Chief Medical Officer of Anavex. “Importantly, we've now observed that the ANAVEX®2-73 (blarcamesine) effect is correlated with changes of Glutamate and GABA levels, objective measures and biomarkers in several neurodevelopmental disorders.”

What happens when the most senior medical officer says.."Hey, we got this CNS thing"? And then the WS axxholes say..."So What"?

Clear to me the science is saying one thing and the WS pukes are saying something else. There is something fundamentally wrong with this scenario. The entire system has to change before the end of the day, IMO.